- Conditions
- Nasal Congestion Associated With the Common Cold
- Interventions
- pseudoephedrine hydrochloride 30 mg tablets, Placebo tablets
- Drug
- Lead sponsor
- Perrigo Company
- Industry
- Eligibility
- 6 Years to 11 Years
- Enrollment
- 565 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 11
- States / cities
- Anaheim, California • Costa Mesa, California • Boise, Idaho + 8 more
Source: ClinicalTrials.gov public record
Updated Apr 21, 2016 · Synced May 22, 2026, 2:48 AM EDT